O'Sullivan 2011.
Methods | 12‐month parallel trial. |
Participants | 83 infants diagnosed with CF in the first 2 months of life who were exclusively bottle fed. |
Interventions | Infant formula containing DHA and AA compared to standard infant formula containing no DHA or AA over 12 months. |
Outcomes | Weight and height at 1 year of age; serum DHA and AA levels, IRT and alpha feto‐protein levels; Brasfield CXR score. |
Notes | Fecal elastase measured at screening and then monthly for the study duration. |
AA: arachidonic acid CF: cystic fibrosis CXR: chest x‐ray DHA: docosahexaenoic acid IRT: immunoreactive trypsin